Per Björk

Identification of Human S100A9 as a Novel Target for Treatment of Autoimmune Disease via Binding to Quinoline-3-Carboxamides

Per Björk, Anders Björk, Thomas Vogl et al. · PLoS Biology · 2009 · 352 citations · Full text

Clinical Immunology, Drug Target, Immunology +20

Proinflammatory S100A12 Can Activate Human Monocytes via Toll-like Receptor 4

Dirk Foell, Helmut Wittkowski, Christoph Kessel et al. · American Journal of Respiratory and Critical Care Medicine · 2013 · 181 citations

Chemical cross‐linking with thiol‐cleavable reagents combined with differential mass spectrometric peptide mapping—A novel approach to assess intermolecular protein contacts

Keiryn L. Bennett, Martin Kussmann, Marie Mikkelsen et al. · Protein Science · 2000 · 150 citations · Full text

S100A9 Interaction with TLR4 Promotes Tumor Growth

Eva Källberg, Thomas Vogl, David Liberg et al. · PLoS ONE · 2012 · 138 citations · Full text

Induction of nuclear factor‐κ<scp>B</scp> responses by the <scp>S</scp>100<scp>A</scp>9 protein is Toll‐like receptor‐4‐dependent

Matteo Riva, Eva Källberg, Per Björk et al. · Immunology · 2012 · 132 citations · Full text